Furthermore, these preliminary data indicate that hepcidin levels are mainly driven by anemia and iron deficiency in EPP patients, which is in line with the concept that these two pathological conditions are hierarchically prevalent over inflammatory signals in hepcidin regulation in humans [53]. This evidence concerns the gene HAMP and anemia (phenotype).